McKesson (NYSE: MCK) reported earnings on July 25. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q1), McKesson met expectations on revenues and crushed expectations on earnings per share.

Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share grew significantly. GAAP earnings per share expanded significantly.

Margins grew across the board.

Revenue details
 McKesson notched revenue of $32.21 billion. The 12 analysts polled by S&P Capital IQ expected sales of $32.50 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $2.07. The 14 earnings estimates compiled by S&P Capital IQ averaged $1.70 per share. Non-GAAP EPS of $2.07 for Q1 were 34% higher than the prior-year quarter's $1.55 per share. GAAP EPS of $1.83 for Q1 were 16% higher than the prior-year quarter's $1.58 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 6.0%, 80 basis points better than the prior-year quarter. Operating margin was 2.1%, 40 basis points better than the prior-year quarter. Net margin was 1.3%, 10 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $32.52 billion. On the bottom line, the average EPS estimate is $2.04.

Next year's average estimate for revenue is $131.44 billion. The average EPS estimate is $8.13.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 625 members out of 650 rating the stock outperform, and 25 members rating it underperform. Among 238 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 231 give McKesson a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $123.87.

Is McKesson the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.